Australia’s biomedical researchers are invited to apply for one of two CSL Centenary Fellowships each worth $1.25million over five years in support of discovery and translational medical research.
Applications opened today for the 2018 Fellowship round. These Fellowships are offered to outstanding mid-career scientists seeking to undertake world-class medical research at an Australian academic institution.
In 2016, in celebration of the company’s 100 year anniversary, CSL established a flagship $25 million Fellowship program to champion excellence in early stage translational research.
As well as paying tribute to CSL’s origins, the Fellowships aim to foster a thriving medical research community by supporting the development of science from benchtop to bedside – a recognised area of need in Australian research.
“Australia is home to CSL’s global hub for early research and translation medicine. We have always been committed to helping grow the quality of Australian research and our biotech environment generally,” said Professor Andrew Cuthbertson AO, CSL Chief Scientific Officer and Director of Research & Development.
“These Fellowships are intentionally long term, high value, and mid-career. I am confident that recipients of the CSL Centenary Fellowships will go on to become some of Australia’s most eminent scientists and will lead the next generation of Australian scientific endeavour.
“We have many brilliant Australians currently building their knowledge in other parts of the world - I hope that some of them will see this as an attractive opportunity to come home and undertake their vital medical research here”, said Professor Cuthbertson.
In 2016, the inaugural Fellowships were awarded to two outstanding scientists; Professor Geoffrey Faulkner and Associate Professor Steven Lane. Both were awarded a $1.25m, five year Fellowship.
Professor Geoffrey Faulkner thinks long-term memory might be stored in our brain’s DNA. He’s testing the idea and what the implications of this might be for people living with Alzheimer’s.
Associate Professor Steven Lane is using genomic testing to personalise leukaemia treatments and discover new drug pathways to reduce relapse rates in older patients.
Two five-year Fellowships will be awarded each calendar year, for ten years. The total value of each award will be A$1.25 million, paid in annual instalments of A$250,000 to the employing institute.
For more information, including applications details, visit: www.cslfellowships.com.au
Media:Christina Hickie
CSL Limited
Phone: +61 9389 3425
Mobile: +61 429 609 762